🇮🇳IN
Sign In
AA

AARTIDRUGS

NSE

Aarti Drugs Ltd

₹374.90

-5.15(-1.36%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

AARTIDRUGS financial summary

For Mar 2026, Aarti Drugs Ltd reported revenue of ₹2,260 crore, which grew 4.0% from the previous year. Net profit was ₹169 crore, which grew 7.6% year on year, on an operating margin of 12%. Earnings per share came in at ₹18.54. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹2,260 crore
Net profit₹169 crore
Operating margin12%
EPS₹18.54

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer